Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-15-020518
Filing Date
2015-01-26
Accepted
2015-01-26 17:14:01
Documents
11
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A d858230d10ka.htm 10-K/A 54141
2 EX-10.17 d858230dex1017.htm EX-10.17 91779
3 EX-10.18 d858230dex1018.htm EX-10.18 362380
4 EX-10.36 d858230dex1036.htm EX-10.36 55776
5 EX-31.3 d858230dex313.htm EX-31.3 2438
6 EX-31.4 d858230dex314.htm EX-31.4 2318
7 GRAPHIC g858230grap001.jpg GRAPHIC 183311
8 GRAPHIC g858230grap002.jpg GRAPHIC 183467
9 GRAPHIC g858230grap003.jpg GRAPHIC 172143
10 GRAPHIC g858230image001.jpg GRAPHIC 13823
11 GRAPHIC g858230img2.jpg GRAPHIC 12962
  Complete submission text file 0001193125-15-020518.txt   1350044
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Filer) CIK: 0001382911 (see all company filings)

EIN.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33415 | Film No.: 15549307
SIC: 2834 Pharmaceutical Preparations